Leonteq Securities AG’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.18M Buy
17,286
+5,968
+53% +$786K 0.08% 172
2026
Q1
$1.58M Sell
11,318
-4,784
-30% -$670K 0.06% 227
2025
Q4
$1.98M Sell
16,102
-6,275
-28% -$763K 0.06% 219
2025
Q3
$2.48M Buy
22,377
+5,475
+32% +$622K 0.08% 181
2025
Q2
$1.87M Buy
16,902
+3,359
+25% +$357K 0.07% 165
2025
Q1
$1.51M Buy
13,543
+682
+5% +$70.4K 0.09% 186
2024
Q4
$1.19M Buy
12,861
+1,392
+12% +$125K 0.08% 212
2024
Q3
$962K Buy
11,469
+7,266
+173% +$554K 0.07% 218
2024
Q2
$288K Sell
4,203
-25,270
-86% -$1.69M 0.02% 415
2024
Q1
$2.16M Sell
29,473
-8,959
-23% -$689K 0.16% 146
2023
Q4
$3.11M Sell
38,432
-6,526
-15% -$508K 0.18% 116
2023
Q3
$3.37M Sell
44,958
-11,638
-21% -$895K 0.19% 118
2023
Q2
$4.36M Sell
56,596
-22,342
-28% -$1.78M 0.23% 108
2023
Q1
$6.55M Buy
78,938
+48,310
+158% +$4M 0.3% 68
2022
Q4
$2.63M Sell
30,628
-31,615
-51% -$2.5M 0.1% 155
2022
Q3
$3.84M Buy
62,243
+3,516
+6% +$222K 0.15% 126
2022
Q2
$3.63M Buy
+58,727
New +$3.64M 0.14% 136
2021
Q1
Sell
-167,967
Closed -$9.79M 1031
2020
Q4
$9.79M Buy
+167,967
New +$10.1M 0.52% 39

Other funds holding GILD

Leonteq Securities AG's GILD Position: Q2 2026 in Review

Leonteq Securities AG increased its Gilead Sciences (GILD) stake by 53% in Q2 2026, buying an estimated $786K and bringing the position to 17,286 shares worth $2.18M. The position accounts for 0.08% of the portfolio, ranked #172.

Leonteq Securities AG first reported a position in GILD in Q4 2020 and has held it in 18 quarters since. The position peaked at $9.79M in Q4 2020. 2,261 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Leonteq Securities AG held 17,286 shares of Gilead Sciences worth $2.18M as of Q2 2026.
  • Leonteq Securities AG bought 5,968 Gilead Sciences shares in Q2 2026, an estimated $786K.
  • Gilead Sciences made up 0.08% of Leonteq Securities AG's portfolio in Q2 2026, its #172 holding.
  • Leonteq Securities AG first reported a position in Gilead Sciences in Q4 2020 and has held it in 18 quarters since.
  • Leonteq Securities AG's Gilead Sciences position peaked at $9.79M in Q4 2020.
  • 2,261 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.